The broadcasting assets of Dogan Yayin, Turkish media conglomerate, are attracting the interest of KKR and TPG. The two of the biggest US private equity businesses, together with Time Warner remained after the second round of bidding. Apax Partners and RTL dropped out of the auction earlier, as they considered the deal price too high. Bids target the television channels Kanal D and Star TV and are expected to exceed USE 1.5billion.

Turkey's Biofarma, a leading generic drug maker, appears to be on the sale block as the company's three co-owners have distributed short sale documents and brought on JPMorgan to advise on the transaction. Citigroup Venture Capital International (CVCI) joins co-investors Partners in Life Sciences (PiLS) and Global Finance in hopes to get as much as USD 500 million out of the deal. CVCI and PiLS originally acquired Biofarma in 2007 for roughly USD 200 million.